Caroline M A van den Bosch1, Suzanne E Geerlings1, Stephanie Natsch2, Jan M Prins1, Marlies E J L Hulscher3. 1. Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Center, University of Amsterdam. 2. Department of Clinical Pharmacology. 3. Department of Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, The Netherlands.
Abstract
BACKGROUND: An important requirement for an effective antibiotic stewardship program is the ability to measure appropriateness of antibiotic use. The aim of this study was to develop quality indicators (QIs) that can be used to measure appropriateness of antibiotic use in the treatment of all bacterial infections in hospitalized adult patients. METHODS: A RAND-modified Delphi procedure was used to develop a set of QIs. Potential QIs were retrieved from the literature. In 2 questionnaire mailings with an in-between face-to-face consensus meeting, an international multidisciplinary expert panel of 17 experts appraised and prioritized these potential QIs. RESULTS: The literature search resulted in a list of 24 potential QIs. Nine QIs describing recommended care at patient level were selected: (1) take 2 blood cultures, (2) take cultures from suspected sites of infection, (3) prescribe empirical antibiotic therapy according to local guideline, (4) change empirical to pathogen-directed therapy, (5) adapt antibiotic dosage to renal function, (6) switch from intravenous to oral, (7) document antibiotic plan, (8) perform therapeutic drug monitoring, and (9) discontinue antibiotic therapy if infection is not confirmed. Two QIs describing recommended care at the hospital level were also selected: (1) a local antibiotic guideline should be present, and (2) these local guidelines should correspond to the national antibiotic guidelines. CONCLUSIONS: The selected QIs can be used in antibiotic stewardship programs to determine for which aspects of antibiotic use there is room for improvement. At this moment we are testing the clinimetric properties of these QIs in 1800 hospitalized patients, in 22 Dutch hospitals.
BACKGROUND: An important requirement for an effective antibiotic stewardship program is the ability to measure appropriateness of antibiotic use. The aim of this study was to develop quality indicators (QIs) that can be used to measure appropriateness of antibiotic use in the treatment of all bacterial infections in hospitalized adult patients. METHODS: A RAND-modified Delphi procedure was used to develop a set of QIs. Potential QIs were retrieved from the literature. In 2 questionnaire mailings with an in-between face-to-face consensus meeting, an international multidisciplinary expert panel of 17 experts appraised and prioritized these potential QIs. RESULTS: The literature search resulted in a list of 24 potential QIs. Nine QIs describing recommended care at patient level were selected: (1) take 2 blood cultures, (2) take cultures from suspected sites of infection, (3) prescribe empirical antibiotic therapy according to local guideline, (4) change empirical to pathogen-directed therapy, (5) adapt antibiotic dosage to renal function, (6) switch from intravenous to oral, (7) document antibiotic plan, (8) perform therapeutic drug monitoring, and (9) discontinue antibiotic therapy if infection is not confirmed. Two QIs describing recommended care at the hospital level were also selected: (1) a local antibiotic guideline should be present, and (2) these local guidelines should correspond to the national antibiotic guidelines. CONCLUSIONS: The selected QIs can be used in antibiotic stewardship programs to determine for which aspects of antibiotic use there is room for improvement. At this moment we are testing the clinimetric properties of these QIs in 1800 hospitalized patients, in 22 Dutch hospitals.
Authors: B Mariani; M Corbella; E Seminari; L Sacco; P Cambieri; F Capra Marzani; I F Martino; M A Bressan; A Muzzi; C Marena; C Tinelli; P Marone Journal: Eur J Clin Microbiol Infect Dis Date: 2017-10-28 Impact factor: 3.267
Authors: Rebekah W Moehring; Deverick J Anderson; Ronda L Cochran; Lauri A Hicks; Arjun Srinivasan; Elizabeth S Dodds Ashley Journal: Clin Infect Dis Date: 2016-12-07 Impact factor: 9.079
Authors: Jacqueline T Bork; Kimberly C Claeys; Emily L Heil; Mary Banoub; Surbhi Leekha; John D Sorkin; Michael Kleinberg Journal: Antimicrob Agents Chemother Date: 2020-07-22 Impact factor: 5.191
Authors: Pablo March-López; Rosa Madridejos; Rosa Tomas; Lucía Boix-Palop; Paula Arcenillas; Lucía Gómez; Emma Padilla; Mariona Xercavins; Laura Martinez; Úrsula Massats; Cristina Badia; Joan Manuel Sánchez Lledó; Alberto Domingo Casino; Jordi Nicolás; Esther Calbo Journal: Antimicrob Agents Chemother Date: 2020-10-20 Impact factor: 5.191
Authors: M C Kallen; M E J L Hulscher; B Elzer; S E Geerlings; P D van der Linden; S Teerenstra; S Natsch; B C Opmeer; J M Prins Journal: J Antimicrob Chemother Date: 2021-05-12 Impact factor: 5.790
Authors: Frederike V van Daalen; Jan M Prins; Brent C Opmeer; Marja A Boermeester; Caroline E Visser; Reinier M van Hest; Marlies E J L Hulscher; Suzanne E Geerlings Journal: BMC Infect Dis Date: 2015-03-19 Impact factor: 3.090
Authors: Marvin A H Berrevoets; Jaap Ten Oever; Jacobien Hoogerwerf; Bart Jan Kullberg; Femke Atsma; Marlies E Hulscher; Jeroen A Schouten Journal: JAC Antimicrob Resist Date: 2019-11-13
Authors: Annemieke K van den Broek; Berend H H Beishuizen; Eric A F Haak; Michiel Duyvendak; Jaap Ten Oever; Chris Sytsma; Mieke van Triest; Cornelia C H Wielders; Jan M Prins Journal: Antimicrob Resist Infect Control Date: 2021-07-03 Impact factor: 4.887